The Business Research Company’s Acute Myeloid Leukemia Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Acute Myeloid Leukemia Global Market Report 2023 evaluates acute myeloid leukemia market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample?id=6100&type=smp
The global acute myeloid leukemia market grew from $1.15 billion in 2022 to $1.29 billion in 2023 at a compound annual growth rate (CAGR) of 12.38%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of acute myeloid leukemia is expected to grow to $2.03 billion in 2027 at a CAGR of 12.03%.
The acute myeloid leukemia market segments in the report are:
1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy
2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy
3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen
4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics
Top Keyplayers
- Pfizer Inc.
- Novartis AG
- Sanofi-Aventis (Genzyme Corporation)
- Bristol Myers Squibb
- Amgen Inc.
Get More Information On The Acute Myeloid Leukemia Market Report:
https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report
The table of contents in TBRC’s acute myeloid leukemia market report includes:
- Executive Summary
- Acute Myeloid Leukemia Market Characteristics
- Acute Myeloid Leukemia Market Trends And Strategies
- Acute Myeloid Leukemia Market – Macro Economic Scenario
- Acute Myeloid Leukemia Market Size And Growth
.
- Acute Myeloid Leukemia Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Acute Myeloid Leukemia Market
- Acute Myeloid Leukemia Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
